Speculative article| Volume 10, ISSUE 2, P103-109, September 1995

Expression of endoglin in psoriatic involved and uninvolved skin

      This paper is only available as a PDF. To read, Please Download here.


      Endoglin is a glycoprotein with TGF-β binding capacity and is predominantly expressed on endothelial cells. In psoriasis, TGF-β has appeared to play a role in the extravasation of peripheral blood mononuclear cells via the endothelium. In order to find out more about the role of endoglin in psoriasis, immunohistochemical staining with PN-E2, a novel anti-endoglin, and of PAL-E, recognizing vascular endothelium, was carried out in psoriatic involved, psoriatic uninvolved and normal skin. The expression of the antigens was assessed semi-quantitatively using a five-point scale. In psoriatic involved skin, a high endoglin expression was found. In psoriatic uninvolved skin, however, we found that endoglin expression was significantly decreased compared with normal skin. The relevance of these findings to the pathogenesis of psoriasis is discussed.



      DMEC (dermal microvascular endothelial cells), HEV (high endothelial venules), IL (interleukin), LTB4 (leukotriene B4), mAb (monoclonal antibody), PBMC (peripheral blood mononuclear cells), PMN (polymorphonuclear leukocytes), TGF-β (transforming growth factor beta), TNF (tumor necrosis factor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Braverman IM
        Electron microscope studies of the microcirculation in psoriasis.
        J Invest Dermatol. 1972; 59: 91-98
        • Braverman IM
        • Cohen I
        • O'Keefe E
        Metabolic and ultrastructural studies in a patient with pustular psoriasis (von Zumbusch).
        Arch Dermatol. 1972; 105: 189-196
        • Braverman IM
        • Sibley J
        Role of the microcirculation in the treatment and pathogenesis of psoriasis.
        J Invest Dermatol. 1982; 78: 12-17
        • Braverman IM
        • Yen A
        Microcirculation in psoriatic skin.
        J Invest Dermatol. 1974; 62: 493-502
        • Braverman IM
        • Yen A
        Ultrastructure of the capillary loops in the dermal papillae of psoriasis.
        J Invest Dermatol. 1977; 68: 53-60
        • Ryan TJ
        The blood vessels of the skin.
        J Invest Dermatol. 1976; 67: 110-118
        • Sackstein R
        • Falanga V
        • Streilein JW
        • Chin YH
        Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction.
        J Invest Dermatol. 1988; 91: 428-432
        • Heng MCY
        • Allen SG
        • Chase DG
        High endothelial venules in involved and uninvolved psoriatic skin: recognition by homing receptors on cytotoxic T lymphocytes.
        Br J Dermatol. 1988; 118: 315-326
        • Macdonald Hull S
        • Goodfield M
        • Wood EJ
        • Cunliffe WJ
        Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser-Doppler flowmetry and immunocytochemical techniques.
        J Invest Dermatol. 1989; 92: 782-785
        • Van de Kerkhof PCM
        • Van Rennes H
        • De Grood R
        • Bauer FW
        • Mier PD
        Metabolic changes at the margin of the spreading psoriatic lesion.
        Br J Dermatol. 1983; 108: 647-652
        • Kemény L
        • Csató M
        • Nyirádi J
        • Gabor M
        • Dobozy A
        Decreased capillary resistance of the uninvolved skin in psoriasis (Letter to the editor).
        Acta Dermatol Venereol. 1988; 68: 459
        • Westphal JR
        • Willems HW
        • Schalkwijk CJM
        • Ruiter DJ
        • de Waal RMW
        A new 180 KD dermal endothelial cell activation antigen: in vitro and in situ characteristics.
        J Invest Dermatol. 1993; 100: 27-34
        • Gougos A
        • St Jacques S
        • Greaves A
        • O'Connell PJ
        • d'Apice AJF
        • Bühring H-J
        • Bernabeu C
        • van Mourik JA
        • Letarte M
        Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts.
        Int Immunol. 1992; 4: 83-92
        • Cheifetz S
        • Bellón T
        • Calés C
        • Vera S
        • Bernabeu C
        • Massagué J
        • Letarte M
        Endoglin is a component of the TGF-β receptor system in human endothelial cells.
        J Biol Chem. 1992; 267: 19027-19030
        • Cai J-P
        • Falanga V
        • Tailor JR
        • Chin Y-H
        Transforming growth factor béta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells.
        J Invest Dermatol. 1992; 98: 405-409
        • Ruiter DJ
        • Schlingemann RO
        • Rietveld FJR
        • De Waal RMW
        Monoclonal antibody defined human endothelial antigens as vascular markers.
        J Invest Dermatol. 1989; 93: 255-325
        • Schlingemann RO
        • Dingjan GM
        • Emeis JJ
        • Blok J
        • Warnaar SO
        • Ruiter DJ
        Monoclonal antibody PAL-E specific for endothelium.
        Lab Invest. 1985; 52: 71-76
        • Braverman IM
        • Yen A
        Ultrastructure of the human dermal micro-circulation. II The capillary loops of the dermal papillae.
        J Invest Dermatol. 1977; 68: 44-52
        • Wong E
        • Camp RD
        • Derm FF
        • Greaves MW
        The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
        J Invest Dermatol. 1985; 84: 421-423
        • Lammers AM
        • Van de Kerkhof PCM
        Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
        Br J Dermatol. 1987; 116: 521-524